The 36-month beta value for BKYI is also noteworthy at 0.30. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for BKYI is 1.78M, and at present, short sellers hold a 2.38% of that float. The average trading volume of BKYI on October 16, 2024 was 2.90M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BKYI) stock’s latest price update
Bio-Key International Inc. (NASDAQ: BKYI) has experienced a decline in its stock price by -9.14 compared to its previous closing price of 0.65. However, the company has seen a fall of -16.34% in its stock price over the last five trading days. globenewswire.com reported 2024-10-14 that BIO-key Accelerates Zero Trust Solutions at Industry-Leading Cybersecurity Conference, ISC2 Security Congress 2024, incl. hosting a session on Passkeys.
BKYI’s Market Performance
Bio-Key International Inc. (BKYI) has experienced a -16.34% fall in stock performance for the past week, with a -64.37% drop in the past month, and a -65.51% drop in the past quarter. The volatility ratio for the week is 9.33%, and the volatility levels for the past 30 days are at 15.83% for BKYI. The simple moving average for the past 20 days is -32.31% for BKYI’s stock, with a -64.73% simple moving average for the past 200 days.
Analysts’ Opinion of BKYI
Many brokerage firms have already submitted their reports for BKYI stocks, with Maxim Group repeating the rating for BKYI by listing it as a “Buy.” The predicted price for BKYI in the upcoming period, according to Maxim Group is $6 based on the research report published on March 26, 2021 of the previous year 2021.
BKYI Trading at -50.08% from the 50-Day Moving Average
After a stumble in the market that brought BKYI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.91% of loss for the given period.
Volatility was left at 15.83%, however, over the last 30 days, the volatility rate increased by 9.33%, as shares sank -55.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -55.86% lower at present.
During the last 5 trading sessions, BKYI fell by -16.34%, which changed the moving average for the period of 200-days by -83.57% in comparison to the 20-day moving average, which settled at $0.8739. In addition, Bio-Key International Inc. saw -80.28% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BKYI starting from DEPASQUALE MICHAEL W, who purchase 20,000 shares at the price of $0.18 back on Dec 01 ’23. After this action, DEPASQUALE MICHAEL W now owns 306,827 shares of Bio-Key International Inc., valued at $3,600 using the latest closing price.
Sullivan James David, the Chief Legal Officer of Bio-Key International Inc., purchase 20,000 shares at $0.17 during a trade that took place back on Nov 30 ’23, which means that Sullivan James David is holding 388,171 shares at $3,300 based on the most recent closing price.
Stock Fundamentals for BKYI
Current profitability levels for the company are sitting at:
- -1.55 for the present operating margin
- 0.11 for the gross margin
The net margin for Bio-Key International Inc. stands at -1.5. The total capital return value is set at 12.16. Equity return is now at value -644.57, with -116.86 for asset returns.
Based on Bio-Key International Inc. (BKYI), the company’s capital structure generated 1.87 points at debt to capital in total, while cash flow to debt ratio is standing at -1.24. The debt to equity ratio resting at -2.15. The interest coverage ratio of the stock is -101.67.
Currently, EBITDA for the company is -8.24 million with net debt to EBITDA at -0.11. When we switch over and look at the enterprise to sales, we see a ratio of 0.36. The receivables turnover for the company is 6.52for trailing twelve months and the total asset turnover is 1.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.54.
Conclusion
In summary, Bio-Key International Inc. (BKYI) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
